This analysis examines the market position and future outlook for Abbott. The profile encompasses global and US specific company strategy, portfolio and pipeline analysis and assessment of financial performance, with US, rest of world and global forecasts for key drugs to 2010. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information
Reasons to Purchase
Understand how Abbott could improve its growth prospects by in-licensing drugs in key growth areas
Benchmark Abbott’s performance against key rivals in the ethical pharmaceuticals sector
Assess the impact of the spin-off of Abbott’s Hospital Products business on the company’s ability to increase investment in its ethical business
